H.R. 4813 · 117th Congress
Matt’s Act
- Stage
- In committee
- Sponsor
- Jeff Fortenberry
- Introduced
- 2021-07-29
- Latest action
- 2021-07-30 · Referred to the Subcommittee on Health.
Summary
Matt's Act
This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge uninsured individuals the average price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.